COST EFFECTIVENESS OF AN INFANT PNEUMOCOCCAL CONJUGATE VACCINE PROGRAM IN CHINA

被引：1
|
作者：
Liu, G.
Zhu, L. [1 ]
Shen, D. [1 ]
Xu, F. [1 ]
Wen, L. [1 ]
Roberts, C. [2 ]
Dong, P. [3 ]
Yue, N. [3 ]
机构：
[1] Peking Univ, China Ctr Hlth Econ Res, Beijing 100871, Peoples R China
[2] Pfizer Inc, New York, NY USA
[3] Pfizer China, Beijing, Peoples R China
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 07期
关键词：
D O I：
10.1016/j.jval.2011.08.926
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A401 / A401
页数：1
相关论文
共 50 条
  • [1] Retrospective Impact Analysis and Cost-Effectiveness of the Pneumococcal Conjugate Vaccine Infant Program in Australia
    Johnna Perdrizet
    Yuen S. Lai
    Scott Williams
    Valda A. Struwig
    Matt Wasserman
    Infectious Diseases and Therapy, 2021, 10 : 507 - 520
  • [2] Estimating the cost-effectiveness of an infant 13-valent pneumococcal conjugate vaccine national immunization program in China
    Shen, Kunling
    Wasserman, Matthew
    Liu, Dongdong
    Yang, Yong-Hong
    Yang, Junfeng
    Guzauskas, Greg F.
    Wang, Bruce C. M.
    Hilton, Betsy
    Farkouh, Raymond
    PLOS ONE, 2018, 13 (07):
  • [3] Retrospective Impact Analysis and Cost-Effectiveness of the Pneumococcal Conjugate Vaccine Infant Program in Australia
    Perdrizet, Johnna
    Lai, Yuen S.
    Williams, Scott
    Struwig, Valda A.
    Wasserman, Matt
    INFECTIOUS DISEASES AND THERAPY, 2021, 10 (01) : 507 - 520
  • [4] The cost effectiveness of pneumococcal conjugate vaccine in the routine infant immunisation programme of The Gambia
    Touray, Morro M. L.
    Hutubessy, Raymond
    Acharya, Arnab
    JOURNAL OF PHARMACEUTICAL HEALTH SERVICES RESEARCH, 2011, 2 (03) : 175 - 184
  • [5] Cost-effectiveness of pneumococcal conjugate vaccine analyzed
    不详
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2000, 57 (09) : 840 - 840
  • [6] Impact and cost effectiveness of pneumococcal conjugate vaccine in India
    Krishnamoorthy, Yuvaraj
    Eliyas, Salin K.
    Nair, Nayana P.
    Sakthivel, Manikandanesan
    Sarveswaran, Gokul
    Chinnakali, Palanivel
    VACCINE, 2019, 37 (04) : 623 - 630
  • [7] Effectiveness of pneumococcal conjugate vaccine
    O'Brien, Katherine L.
    Levine, Orin S.
    LANCET, 2006, 368 (9546): : 1469 - 1470
  • [8] Review of vaccine effectiveness assumptions used in economic evaluations of infant pneumococcal conjugate vaccine
    Wasserman, Matt
    Sings, Heather L.
    Jones, Dylan
    Pugh, Sarah
    Moffatt, Margaret
    Farkouh, Raymond
    EXPERT REVIEW OF VACCINES, 2018, 17 (01) : 71 - 78
  • [9] Cost-effectiveness of a national immunization program with the 13-valent pneumococcal conjugate vaccine compared with the 10-valent pneumococcal conjugate vaccine in South Korea
    Kim, Hye-Young
    Park, Seong-Beom
    Kang, Eun-Sil
    Lee, Sang-Min
    Kim, Hyun-Jin
    Wasserman, Matt
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (03) : 909 - 918
  • [10] Cost-effectiveness of a 3-dose pneumococcal conjugate vaccine program in the province of Quebec, Canada
    Poirier, Beatrice
    De Wals, Philippe
    Petit, Genevieve
    Erickson, Lonny J.
    Pepin, Jacques
    VACCINE, 2009, 27 (50) : 7105 - 7109
12345